Elanco Animal Health (ELAN) Debt to Equity (2018 - 2026)

Elanco Animal Health has disclosed Debt to Equity across 9 years of filings, most recently posting $0.61 for Q1 2026.

• Debt to Equity for Q1 2026 came in at $0.61, down 11.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.61 (down 11.25% YoY), and the FY2025 annual result was $0.61, down 13.44% from the prior year.
• Debt to Equity came in at $0.61 for Q1 2026 at Elanco Animal Health, roughly flat from $0.61 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.96 in Q3 2023 to a low of $0.6 in Q3 2025.
• The 5-year median for Debt to Equity is $0.8 (2023), against an average of $0.78.
• Across the five-year window, Debt to Equity rose 18.28% in 2024 and plunged 34.96% in 2025, its largest moves.
• Elanco Animal Health's Debt to Equity stood at $0.8 in 2022, then advanced by 15.89% to $0.93 in 2023, then fell by 23.61% to $0.71 in 2024, then slipped by 13.44% to $0.61 in 2025, then increased by 0.07% to $0.61 in 2026.
• The last three Debt to Equity figures came in at $0.61 (Q1 2026), $0.61 (Q4 2025), and $0.6 (Q3 2025), per Business Quant data.